Wellcome Trust Sanger Institute accelerates genetics research
The Wellcome Trust Sanger Institute, a charitably-funded genomic research centre in Hinxton, UK, has selected DataDirect Networks (DDN) technology to help power its genetics research. The Wellcome Trust Sanger UK10K project, which aims to sequence the DNA of 10,000 individuals, will use the DDN SFA10000 storage platform powering a DDN ExaScaler parallel file system. This is suited to scale-out performance to meet the challenges of sequence alignment and bioinformatics processing, while also scaling-up to efficiently manage petabytes of genomic research data in terms of both cost and space.
The Wellcome Trust Sanger Institute is best known for its contribution to the human genome project, decoding more than one-third of the human genome and producing nearly one billion bases of DNA sequence. It has focused on areas such as bioinformatics and human genetics to help advance efforts to help scientists tackle cancer and neurological diseases.